FDA notifications. FDA tentatively approves generic lamivudine.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine